Cargando…
Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity
BACKGROUND: We counsel our triple-negative breast cancer (TNBC) patients that the risk of recurrence is highest in the first 5 years after diagnosis. However, there are limited data with extended follow-up on the frequency, characteristics, and predictors of late events. METHODS: We queried the MD A...
Autores principales: | Reddy, S M, Barcenas, C H, Sinha, A K, Hsu, L, Moulder, S L, Tripathy, D, Hortobagyi, G N, Valero, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765226/ https://www.ncbi.nlm.nih.gov/pubmed/29235566 http://dx.doi.org/10.1038/bjc.2017.379 |
Ejemplares similares
-
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
por: Norton, Nadine, et al.
Publicado: (2020) -
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023) -
Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis
por: Chen, Cai-Ping, et al.
Publicado: (2022) -
Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
por: Mlole, Angela T, et al.
Publicado: (2020) -
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
por: Yau, Christina, et al.
Publicado: (2010)